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Introduction
In the USA, more than ﬁ   ve million patients require 
central venous access each year. Unfortunately, central 
venous access can be associated with adverse events that 
are hazardous to patients and expensive to treat. 
Infection remains the main complication of intravascular 
catheters in critically ill patients. Catheter-related blood-
stream infections have been reported to occur in 3 to 8% 
of inserted catheters and are the ﬁ  rst cause of nosocomial 
bloodstream infection in intensive care units (ICUs), with 
80,000 cases annually at a cost of $300 million to $2.3 
billon [1]. Additional ﬁ  nancial costs may be as high as 
$30,000 per survivor, including one extra week in the 
ICU and two to three additional weeks in the hospital. 
Attributable mortality rates range from 0 to 35%, 
depending on the degree of control for severity of illness.
Th   e physiopathology of catheter infection is now more 
clearly understood. Colonization of the endovascular tip 
of the catheter precedes infection and arises by two main 
pathways: Th  e extraluminal and the intraluminal routes 
(Fig. 1) [2]. Migration of skin organisms from the inser-
tion site into the cutaneous catheter tract with coloniza-
tion of the catheter tip is the most common route of 
infection for short-term central venous catheters (CVCs). 
For long-term catheters (i.e., catheters staying in place 
more than 15 days), the main cause of colonization is 
manipulation of the venous line with migration of 
organisms along the internal lumen of the catheter. Th  e 
adherence properties of microorganisms to host proteins, 
such as ﬁ  bronectin, commonly present on catheter tips 
make this colonization easier. Coagulase-negative 
staphylo  cocci are the most common microorganisms 
associated with catheter-related bloodstream infections. 
Other microorganisms commonly involved include 
Staphylococcus aureus, Candida species, Enterococci and 
Gram-negative bacilli [3].
Th  e Centers for Disease Control and Prevention 
identiﬁ   es catheter-associated adverse events, including 
bloodstream infections, as one of its seven health care 
safety challenges, with a goal to reduce such compli  ca-
tions by 50% in ﬁ  ve years [4]. Several preventive measures 
have been studied to reduce the incidence of these 
infections. Th  e most eﬀ   ective are those that reduce 
colonization at the catheter skin insertion site or the 
infusion line, and include: Adequate knowledge and use 
of care protocols; qualiﬁ  ed personnel involved in catheter 
changing and care; use of biomaterials that inhibit 
microorganism growth and adhesion; good hand hygiene; 
use of an alcoholic formulation of chlorhexidine for skin 
disinfection and manipulation of the vascular line; 
preference for the subclavian vein route for insertion of 
CVCs using full-barrier precautions; and removal of 
unnecessary catheters.
Catheter care protocols
Programs that help health-care providers to monitor and 
evaluate care are crucial for the success of preventive 
measures. Educational programs with hygiene training 
and written protocols concerning catheter insertion (e.g., 
preparation of the equipment, skin antisepsis, detailed 
insertion techniques), catheter manipulation (e.g., hand 
hygiene, manipulations of taps) and catheter care (e.g., 
catheter replacement modalities, type and frequency of 
dressings, and line repair) are eﬀ   ective when staﬀ   
members are involved in designing the measures 
included in the program [5, 6]. Regular evaluation of the 
incidence of catheter-related infections and of clinical 
practice is a useful measure when information and 
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in emergency conditions increases the risk of non-com-
pliance to the insertion protocol and, consequently, to 
infectious complications; these catheters must be replaced 
as soon as the patient’s condition is stabilized [9].
Staff   educational/quality improvement program
Educating and training of health-care providers who 
insert and maintain CVCs is essential for preventing 
catheter-related infection, improving patient outcomes, 
and reducing healthcare costs [10]. Th   e experience of the 
operator is an important issue as the risk of infectious 
complications is inversely proportional to the operator 
skills. An educational intervention in catheter insertion 
signiﬁ  cantly improved patient outcomes and simulation-
based training programs are valuable in residency 
education [11]. Programs for training nurses in long-
term catheter care (“IV teams”) were associated with a 
reduction in catheter-related infections in the USA [12]. 
Nevertheless, without such teams the use of care 
protocols and nursing staﬀ   education allowed comparable 
results to be obtained [13]. Nursing staﬀ    reductions 
below a critical level may contribute to increase catheter-
related infection by making adequate catheter care 
diﬃ   cult. One study reported a four times greater risk of 
catheter infection when the patient-to-nurse ratio was 
doubled [14]. Moreover, replacement of regular nurses by 
ﬂ  oat nurses further increases the risk of device-related 
infections [15]. Th   ese studies clearly indicate that trained 
nurses, in suﬃ     cient numbers, must be available for 
optimal patient care in the ICU.
Type of catheter
Catheter material is an important determinant in the 
prevention of catheter-related infection. Th  e material 
should be biocompatible, hemocompatible, biostable, 
chemically neutral, not altered by administered drugs, 
and deformable according to surrounding strengths. 
Furthermore, the catheter must be ﬂ  exible, resistant, as 
radio-opaque as possible, thin walled with a high internal 
to external diameter ratio, resistant to sterilization, and 
with locked connections such as ‘luer-lock’ type. Teﬂ  on® 
or polyurethane catheters have been associated with 
fewer infectious complications than catheters made of 
polyvinyl chloride or polyethylene [16, 17]. Th  e  majority 
of catheters sold in the USA and in many European 
countries are, therefore, no longer made of polyvinyl 
chloride or polyethylene.
Catheters coated with antimicrobial or antiseptic 
agents decrease microorganism adhesion and bioﬁ  lm 
production, and, hence, the risk of catheter-related infec-
tion. Th   e use of such catheters may potentially decrease 
hospital costs, despite the additional acquisition cost of 
the antimicrobial/antiseptic coated catheter [18]. Commer-
cialized catheters are mainly coated with chlorhexidine/
silver sulfadiazine or minocycline/rifampin [19]. Fifteen 
randomized studies evaluating the performance of a 
catheter coated on its extraluminal side with chlor-
hexidine/silver sulfadiazine (ﬁ  rst generation) were included 
in a meta-analysis. Compared to a standard catheter, the 
use of the coated catheter decreased the risk of catheter 
colonization (relative risk, RR: 0.59 [95% CI: 0.50–0.71]) 
and bloodstream infection (RR: 0.66 [95% CI: 0.47–0.93]) 
[20]. Two studies evaluated catheters coated on both 
their external and internal surfaces (second generation) 
and provided comparable results concerning colonization 
(RR: 0.44 [95% CI: 0.23–0.85]) and a non-signiﬁ  cant 
reduction in bloodstream infection (RR: 0.70 [95% CI: 
0.30–1.62]), probably due to a lack of power. Five studies 
evaluated catheters covered with minocycline/rifampin 
and reported a decrease in colonization (RR: 0.40 [95% 
CI: 0.23–0.67]) and bloodstream infection (RR: 0.39 [95% 
CI: 0.17–0.92]) compared to standard catheters. Two 
studies concluded that silver-coated catheters (even with 
platinum or carbon coating) had no beneﬁ  cial eﬀ  ects on 
colonization (RR: 0.76 [95% CI: 0.57–1.01]) or on 
bloodstream infection (RR: 0.54 [95% CI: 0.16–1.85]), but 
the studies were underpowered. A multicenter random-
ized study evaluated catheters impregnated with ionic 
silver in 577 ICU patients and 617 CVCs [21]. Compared 
to standard catheters, impregnated catheters had no 
eﬀ  ect on colonization (RR: 1.24 [95% CI: 0.83–1.85]) or 
bloodstream infection prevention (RR: 0.93 [95% CI: 
0.35–2.44]). Two studies compared ﬁ  rst generation anti-
septic catheters with antibiotic-coated catheters and 
concluded that the latter were superior for preventing 
Figure 1. Pathophysiology of central line infection.
Intraluminal route
Extraluminal route
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bloodstream infection (RR: 0.12 [95% CI: 0.02–0.67]). No 
study has compared antibiotic-coated catheters with 
second generation antiseptic impregnated catheters. At 
this time, there is no evidence for multi-resistant bacteria 
selection with antibiotic-coated catheters, but the 
number of studies is limited. Rare but serious cases of 
anaphylactic reactions to chlorhexidine/silver sulfadia-
zine have been reported, mainly in Japan. However, 
despite a Food and Drug Administration (FDA) alert in 
1998 encouraging the declaration of these events, the 
number of cases reported in the USA remains low. 
Considering their costs and their theoretical ecological 
impact, the use of CVCs coated with antimicrobial agents 
should be reserved for ICUs where the incidence of 
catheter-related infection remains high despite adherence 
to guidelines and recommended measures [22].
CVCs with multiple lumens allow simultaneous 
adminis  tration of incompatible drugs and may separate 
the administration of vasopressors and parenteral 
nutrition. Five randomized studies have evaluated the 
risk of the use of multilumen catheters on catheter 
colonization and bloodstream infection [23]. Most of 
these studies are old, were conducted outside the ICU, 
and included few patients. Compared to mono-lumen 
catheters, the use of multiple lumen catheters was asso-
ciated with comparable risks of catheter colonization 
(RR: 0.80 [95% CI: 0.43–1.50]), but higher risks of 
bloodstream infection (RR: 2.26 [95% CI: 1.06–4.83]). 
Th   e increased risk of bloodstream infection is explained 
by one study which included long-term catheters (mean 
duration of catheterization longer than 20 days) for 
parenteral nutrition and reported a surprisingly high 
level of infection with multiple lumen catheters (13.1% 
versus 2.6% with mono-lumen catheters). Excluding this 
study from the meta-analysis gave a comparable risk of 
bloodstream infection between the groups (RR: 1.29 [95% 
CI: 0.49–3.39]). Th  e choice of the number of lumens 
should, therefore, be made based on the patient’s require-
ments rather than on the risk of infectious complications. 
Any solution containing lipids (parenteral nutrition, 
propofol) must be delivered through a dedicated lumen.
Catheter insertion site
Th   e site at which a catheter is inserted may inﬂ  uence the 
subsequent risk of catheter-related infection because of 
diﬀ  erences in the density of local skin ﬂ  ora and risks of 
thrombophlebitis. A randomized study of 270 catheters 
inserted in the femoral or subclavian veins of ICU 
patients [24] reported a higher colonization rate with 
femoral catheters (RR: 6.4 [ 95% CI: 1.9–21.2]) without 
any increase in bloodstream infections (RR: 2.0 [ 95% CI: 
0.2–22.1]). A meta-analysis of three prospective non-
randomized studies compared catheters inserted in the 
internal jugular (n = 278) and subclavian (n = 429) veins. 
Th   e use of the internal jugular vein was associated with a 
non-signiﬁ   cant increase in the risk of bloodstream 
infection (RR: 2.24 [95% CI: 0.2–22.1]) compared to the 
subclavian route. Moreover, multivariate analysis of 
several prospective studies has shown more frequent 
infectious complications when using femoral or internal 
jugular access [25].
A randomized multicenter study evaluated the risk of 
complications with dialysis catheters in the ICU accord-
ing to femoral or internal jugular insertion site. A total of 
750 catheters with an average duration of insertion of 
6  days were included. Th  e risk for colonization was 
comparable for both sites (incidence of 40.8 vs 35.7 per 
1000 catheter-days for the femoral and jugular sites, 
respectively, RR: 0.85 [95% CI: 0.62–1.16]). Nevertheless, 
the risk of colonization with internal jugular access was 
increased in patients with a body mass index less than 
24.2 (RR: 2.10 [95% CI: 0.23–0.69]) and decreased in 
patients with a body mass index greater than 28.4 
(RR: 0.40 [95% CI: 1.13–3.91]) [26].
Th  e subclavian site is preferred for infection control 
purposes, although other factors (e.g., the potential for 
mechanical complications, risk of subclavian vein 
stenosis, and catheter-operator skill) should be con-
sidered when deciding where to place the catheter. When 
the subclavian route is contraindicated, the choice 
between the femoral and internal jugular vein should be 
made according to the body mass index of the patient. 
Th  e risk of thrombophlebitis should also be taken into 
consideration, as it is higher with the femoral route than 
when using the subclavian or internal jugular veins.
Ultrasound-guided placement
Th   e use of ultrasound guidance has been promoted as a 
method to reduce the risk of complications during central 
venous catheterization. In this technique, an ultrasound 
probe is used to localize the vein and to measure its 
depth beneath the skin. Under ultrasound visualization, 
the introducer needle is then guided through the skin 
and into the vessel. Th  e location of the vein with 
ultrasound decreases the number of puncture failures 
and complications (e.g., arterial puncture), and reduces 
the time for catheter insertion. Th  is technique may 
provide advantages for the jugular internal vein location. 
In a meta-analysis of eight studies, the use of bedside 
ultrasound for the placement of catheters substantially 
reduced mechanical complications compared with the 
standard landmark placement technique (RR: 0.22; [95% 
CI: 0.10–0.45]) [27]. Data available for subclavian or 
femoral veins are encouraging but limited. In a random-
ized study with 900 ICU patients, ultrasound-guided 
place  ment resulted in a reduction in bloodstream infec-
tion (10.4% vs 16.0%, p < 0.01) [28]. In hospitals where 
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adequate training, the use of ultrasound guidance should 
be routinely considered before CVC placement is 
attempted.
Insertion technique
When inserting a catheter, one should use maximal 
sterile-barrier precautions, including a mask, a cap, a 
sterile gown, sterile gloves, and a large sterile drape. Th  is 
approach has been shown to reduce the rate of catheter-
related bloodstream infections and to save an estimated 
$167 per catheter inserted [29]. Th   e insertion site should 
be widely disinfected with a chlorhexidine-based solu-
tion. Catheters should then be inserted using the 
Seldinger technique and adequately secured.
Skin antisepsis
Th   e density of microorganisms at the catheter insertion 
site is a major risk factor for catheter-related infection 
and skin antisepsis is one of the most important 
preventive measures. Povidone iodine and chlorhexidine 
are the most commonly used antiseptic agents, both 
available as aqueous and alcoholic solutions. Th  eir 
respec tive  eﬃ     cacy in preventing catheter colonization 
and bloodstream infections has been compared in 
numerous studies.
One meta-analysis included eight randomized trials 
that compared chlorhexidine to aqueous povidone iodine 
for the care of 4143 short-term catheters (1568 CVC, 
1361 peripheral venous catheters, 704 arterial catheters, 
and 395 pulmonary artery catheters) in hospitalized 
patients [30]. Chlorhexidine solutions were either an 
aqueous solution of 2% chlorhexidine (2 trials), a 70% 
alcoholic solution of 0.5% chlorhexidine (4 trials), an 
alcoholic solution of 1% chlorhexidine (1 trial), or a 
combination of 0.25% chlorhexidine, 0.025% benzalko-
nium chloride and 4% benzylic alcohol (1 trial). Catheter 
insertion sites and duration of catheterization were 
comparable between the two groups. Th   e use of 
chlorhexidine rather than povidone iodine aqueous 
solution signiﬁ   cantly reduced catheter-related blood-
stream infections by approximately 50% (RR: 0.51 [95% 
CI, 0.27–0.97]). For every 1000 catheter sites disinfected 
with chlorhexidine solutions rather than povidone iodine 
solutions, 71 episodes of CVC colonization and 11 
episodes of infections would be prevented. Similar 
ﬁ   ndings with an alcoholic formulation of 2% chlor-
hexidine were reported after publication of the meta-
analysis [31], conﬁ  rming that aqueous povidone iodine 
should not be used for this indication.
In most of these studies, chlorhexidine’s superiority 
was explained, at least in part, by a synergistic eﬀ  ect with 
alcohol, even for low chlorhexidine concentrations. Th  is 
synergistic eﬀ  ect was also demonstrated with povidone 
iodine. A randomized multicenter crossover trial com-
pared the eﬀ  ectiveness of two pre-insertion cutaneous 
antisepsis protocols using aqueous 10% povidone-iodine 
or a solution of 5% povidone iodine in 70% ethanol [32]. 
Th  e incidences of catheter colonization (RR: 0.38 [95% 
CI: 0.22–0.65]) and catheter-related infection (RR: 0.34 
[95% CI: 0.13–0.91]) were signiﬁ  cantly lower in patients 
managed using the alcoholic povidone iodine solution 
protocol compared to the aqueous povidone iodine 
solution protocol. No signiﬁ  cant eﬀ  ect was observed on 
bloodstream infections, but the study was underpowered 
to explore this issue.
Only one trial has compared a chlorhexidine-based 
solution to 5% alcoholic povidone iodine. A total of 538 
catheters were randomized and 481 (89.4%) produced 
evaluable culture results [33]. Compared to alcoholic 
povidone iodine, the used of a chlorhexidine-based 
solution signiﬁ  cantly reduced the incidence of catheter 
colonization by 50% (11.6% vs 22.2% p = 0.002; incidence 
density, 9.7 vs 18.3 per 1000 catheter-days). Th  e use of 
the chlorhexidine-based solution was also associated 
with a trend toward lower rates of catheter-related blood-
stream infection (1.7% vs 4.2% p = 0.09; incidence density, 
1.4 vs 3.4 per 1000 catheter-days). In this study, indepen-
dent risk factors for catheter colonization were catheter 
insertion in the jugular vein (RR: 2.01 [95% CI: 1.24–3.24]) 
and use of alcoholic povidone iodine as skin disinfectant 
(RR: 1.87 [95 CI: 1.18–2.96]). Although more studies are 
needed to conﬁ   rm these results, chlorhexidine-based 
solutions do seem to be more eﬀ  ective than povidone 
iodine, even in an alcoholic formulation, and should be 
used as ﬁ  rst-line antiseptics for CVC care.
Tolerance to chlorhexidine-based solutions is generally 
excellent. Contact dermatitis is occasionally observed 
whatever the formulation used and severe anaphylactic 
reactions have been exceptionally reported (less than 100 
cases in the world).
Antibiotic prophylaxis
No studies have demonstrated any reduction in CVC 
infection rates with oral or parenteral antibacterial or 
antifungal drugs given during catheter insertion. In 
contrast, numerous studies have reported that antibiotic 
administration in patients with a CVC in situ signiﬁ  cantly 
reduced the risk of catheter colonization and of blood 
stream infections [24]. In pediatric patients, two studies 
have assessed vancomycin prophylaxis for CVC ﬂ  ushing 
(antibiotic lock); both demonstrated a signiﬁ  cant 
reduction in catheter-related bloodstream infection with-
out any eﬀ  ect on mortality [34, 35]. Because prophylactic 
use of vancomycin is an independent risk factor for 
vancomycin-resistant  Enterococcus (VRE) acquisition, 
the risk of VRE emergence likely outweighs the beneﬁ  t of 
using prophylactic vancomycin. Systemic antibiotic 
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or maintenance just for the purpose of preventing 
catheter infection.
Tunneling
Subcutaneous tunneling of short-term CVCs is thought 
to reduce the incidence of catheter infection, presumably 
by increasing the distance between the venous entry site 
and skin emergence. Catheter emergence in a skin area 
that is less colonized by skin pathogens is another 
possible mechanism. Another advantage of tunneling is 
better ﬁ  xation of the catheter. Evidence from studies on 
tunneling eﬃ     cacy have suggested that this technique 
reduces CVC infections in patients with short-term 
devices, where most colonized pathogens arise from the 
catheter insertion site. A meta-analysis of randomized 
controlled trials demonstrated that tunneling decreased 
catheter colonization by 39% and bloodstream infection 
by 44% compared to non-tunneling [36]. Th  ese results 
were partly due to one trial with CVCs inserted via the 
internal jugular vein, and no signiﬁ  cant risk reduction 
was observed when only the data from ﬁ  ve subclavian 
catheter trials were pooled. Mechanical complications or 
diﬃ     culties during placement were not increased by 
tunneling but these outcomes were not evaluated in 
depth. Although, this meta-analysis concluded that 
tunneling decreased catheter-related infections, the data 
do not support routine subcutaneous tunneling of short-
term venous catheters unless subclavian access is not 
possible (or contraindicated) and the duration of 
catheterization is anticipated to be more than 7 days.
Dressing
Because occlusive dressings trap moisture on the skin 
and provide an ideal environment for quick local micro-
ﬂ   ora growth, dressings for insertion sites must be 
permeable to water vapor. Th   e two most common types 
of dressing used are sterile, transparent, semi-permeable 
polyurethane dressings coated with a layer of an acrylic 
adhesive, and gauze and tape dressings. Transparent, 
semipermeable polyurethane dressings have become a 
popular way of dressing catheter insertion sites because 
they allow continuous visual inspection of the site, allow 
patients to have baths and to shower without saturating 
the dressing, and require less frequent changes than do 
standard gauze and tape dressings; ﬁ  nally these dressings 
are time-saving for the staﬀ   . However, as there is no 
evidence regarding which type of dressing provides the 
greatest protection against infection the choice of dressing 
can be a matter of preference. If blood is oozing from the 
catheter insertion site, a gauze dressing may be preferred.
In a meta-analysis, the use of a chlorhexidine-impreg-
nated sponge placed over the site of short-term vascular 
and epidural catheters signiﬁ  cantly reduced the risk of 
catheter colonization but not catheter-related blood-
stream infection compared to standard dressing [37]. 
More recently, a study performed in seven ICUs in 
France included 1636 patients randomized to receive 
catheter dressings with or without a chlorhexidine 
gluconate-impregnated sponge [38]. A total of 3778 
catheters (28,931 catheter-days) were evaluated. Th  e 
median duration of catheter insertion was 6 (interquartile 
range, 4–10) days. Use of chlorhexidine gluconate-
impreg  nated sponge dressings decreased the rates of 
major catheter-related infections (10/1953 [0.5%], 0.6 per 
1000 catheter-days vs 19/1825 [1.1%], 1.4 per 1000 
catheter-days; hazard ratio [HR], 0.39 [95% CI, 0.17–
0.93]; p = 0.03) and catheter-related bloodstream infec-
tions (6/1953 catheters, 0.40 per 1000 catheter-days vs 
17/1825 catheters, 1.3 per 1000 catheter-days; HR, 0.24 
[95% CI, 0.09–0.65]). Use of chlorhexidine gluconate-
impregnated sponge dressings was not associated with 
greater resistance of bacteria in skin samples at catheter 
removal and was well tolerated. Th  e authors concluded 
that the use of chlorhexidine gluconate-impregnated 
sponge dressings with intravascular catheters in the ICU 
reduced the risk of infection even when background 
infection rates were low, and should be recommended 
[38]. However, the antiseptic solution used for catheter 
care was povidone iodine. As previously discussed, 
chlorhexidine is more eﬀ  ective than povidone iodine to 
disinfect the skin. Th   erefore, whether there is any beneﬁ  t 
from using chlorhexidine-impregnated sponge for 
catheters in patients in whom chlorhexidine is used for 
catheter care remains unknown.
Th   e optimal frequency for routine changing of catheter 
dressings is unknown. It is probably of little use to change 
dressing before 7 days, except when the insertion site is 
soiled with blood or moisture or the dressing is unstuck 
[38]. Th  e dressing site should be disinfected with the 
same antiseptic solution used for catheter placement.
Venous line maintenance
Th  e optimal time interval for routine replacement of 
intra  venous administration sets has been studied in three 
well-controlled trials [39–41]. Replacing administration 
sets no more frequently than 72 hours after initiation of 
use is safe and cost-eﬀ  ective [42]. Because blood, blood 
products, and lipid emulsions (including parenteral 
nutrition and propofol) have been identiﬁ  ed as indepen-
dent risk factors for catheter-related infection [43], 
tubing used to administer these products should be 
replaced within 24 hours or immediately after the end of 
administration.
An aseptic technique is very important when accessing 
the system. Catheter, tubing, or syringe manipulations 
must be done only after cleaning hands with an alcohol-
based handrub solution. Hubs and sampling ports should 
Frasca et al. Critical Care 2010, 14:212 
http://ccforum.com/content/14/2/212
Page 5 of 8be disinfected with chlorhexidine-based antiseptic solu-
tions before accessing [44]. During prolonged catheteri-
zation, infection risk is strongly connected to the 
duration of catheter stay and frequent catheter hub 
access increases catheter-related infection risk from 
colonized catheter hubs rather than from the insertion 
site. Th   e number of manipulations of the central venous 
line, especially when an aseptic technique is not 
respected, increases the risk of catheter-related 
bloodstream infection. Th  e use of the enteral or oral 
route to deliver drugs and diet should, thus, be 
encouraged whenever possible.
Th   e continued need for the catheter should be assessed 
every day and removal considered when the catheter is 
no longer essential for medical management. Catheter 
replacement at scheduled time intervals as a method to 
reduce catheter-related infection has not been shown to 
be beneﬁ  cial [45, 46]. Scheduled guidewire exchanges of 
catheters have also been proposed, but a meta-analysis of 
12 randomized controlled trials failed to demonstrate any 
reduction in infection rates with routine guidewire 
exchange compared to catheter replacement on an as-
needed basis [47]. On the contrary, exchanging catheters 
with the use of a guidewire increases the risk of blood-
stream infection, while replacement involving insertion 
of catheters at new sites increases the risk of mechanical 
complications [46]. Th   us, routine replacement of CVCs is 
not necessary for functional catheters with no evidence 
of local or systemic complications. Catheter guidewire 
exchange is acceptable for replacement of a non-
functional catheter.
Application of antibiotic or antiseptic ointments (e.g., 
bacitracin, mupirocin, neomycin, and polymyxin) to 
catheter-insertion sites increases the rate of catheter 
colonization by fungi, promotes the emergence of 
antibiotic-resistant bacteria, and has not been shown to 
lower the rate of catheter-related bloodstream infections 
[48]. Th  ese ointments should not be used. No data are 
available to support the eﬃ     cacy of in-line ﬁ  lters  in 
prevent  ing infections associated with intravascular 
catheters and infusion systems, although the use of these 
devices increases the cost of the venous line. Adminis-
tration of prophylactic heparin reduces the risk of 
thrombosis around the catheter. Because thrombi and 
ﬁ  brin deposits on catheters may be a nidus for microbial 
colonization of intravascular catheters, anticoagulant 
therapy may have a role in prevention [49]. Moreover, 
these agents are also indicated in the management of in-
bed patients with multiple risk factors for venous 
thrombosis.
Conclusion
Catheter-related bloodstream infection remains the most 
serious complication of central venous access and a 
leading cause of nosocomial infection in the ICU. 
Prevention of catheter-related infection involves several 
measures which should be used in combination (Table 1) 
[50–52]. Th  e most important include the use of a 
checklist to guide catheter insertion and maintenance; 
adequate training of the nursing staﬀ    involved in the 
management of vascular access and an adequate patient-
to-nurse ratio; the use of maximal sterile barrier 
precautions during catheter insertion; preference for a 
chlorhexidine-based solution for skin antisepsis and use 
of the subclavian vein whenever possible; cleaning hands 
with an alcohol-based handrub solution before any 
manipulation of the infusion line; and removing any 
useless catheters. Th   e use of antimicrobial-coated CVCs 
should be reserved for ICUs where the incidence of 
catheter-related infection remains high despite adherence 
Table 1. Interventions to prevent central venous catheter (CVC) infection
•  Use protocols for catheter insertion and maintenance
•  Check for adequate training, experience, and numbers of nurses caring for patients with CVC
•  Use antimicrobial-coated CVCs if the incidence of catheter-related infection remains high despite adherence to guidelines and recommended measures
•  Use maximal sterile-barrier precautions during catheter insertion
•  Insert catheters using the subclavian venous site
•  Use ultrasound guidance during catheterization (?)
•  Consider tunneling if subclavian access is not possible and the CVC is anticipated to be in situ for more than 7 days
•  Clean hands with an alcohol-based handrub solution before any manipulation of the infusion line
•  Change dressings not more frequently than 7 days if not soiled, wet, or unstuck
•  Avoid the use of antibiotic prophylaxis at catheter insertion, and antibiotic ointments or inline fi  lters during catheter maintenance
•  Use the enteral route or peripheral venous access instead of the CVC as soon as possible
•  Do not schedule routine catheter changes
•  Remove catheters when they are no longer needed
Frasca et al. Critical Care 2010, 14:212 
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Page 6 of 8to guidelines and recommended measures. As with any 
device used in the ICU, healthcare workers caring for a 
patient with a central venous access device need to be 
adequately trained, and assessed as being competent in 
using CVCs and adhering to infection prevention 
practices.
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